Myelopathy Because of CAR-T-Related Neurotoxicity Treated With Siltuximab
Yasmin Aghajan1, Alison Yu1, Caron A Jacobson1
1Department of Neurology (YA, HV) and Department of Radiology (MR), Brigham and Women's Hospital, Boston; Department of Hematology and Oncology (AY, LK), Boston Children's Hospital; and Department of Oncology (CAJ, AIK), Dana Farber Cancer Institute, Boston, MA.
Neurology. Clinical Practice
|January 7, 2022
Abstract
No abstract available in PubMed .
More Related Videos
09:34Dynamic Imaging of Chimeric Antigen Receptor T Cells with [18F]Tetrafluoroborate Positron Emission Tomography/Computed Tomography
Published on: February 17, 2022
3.5K
09:12Author Spotlight: Advancements in Hypoxia-Sensitive CAR-T Therapy for Enhanced Cancer Immunotherapy
Published on: June 14, 2024
1.0K
